Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Feraccruferaccru.com · Low evidenceFeraccru is a ferric maltol product developed by Shield Therapeutics for iron supplementation. It is designed to treat iron deficiency in patients who cannot tolerate or have inadequate response to oral iron therapies.
Parse Score